Agfa HealthCare's stated core belief is centered around helping imaging providers succeed, yet a majority of U.S. clients interviewed by KLAS report gaps in reaching desired results when using Agfa as a vendor. The reasons and other details can be found in the new KLAS vendor-specific report Agfa HealthCare Study 2013: Partnering with Agfa in 2013.
Fujifilm Medical Systems U.S.A. Inc. launched the Synapse Vendor Neutral Archive (VNA) into its informatics portfolio. The technology will enable customers to manage all types of data generated within their healthcare institution. Instead of the data being standards or non-standards based, Synapse VNA technology will catalog and maintain the data in a patient centric model allowing a single access point for EMRs and other systems.
TeraRecon highlighted the broad capability of its flagship iNtuition enterprise image management solution to support enterprise-wide vendor-neutral viewing of medical images, at the annual meeting of the Healthcare Information and Management Systems Society, (HIMSS), March 4-6, 2013.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
Bayer Healthcare is expanding its global distribution network for the Medrad Intego positron emission tomography (PET) Infusion System through a new distribution agreement with Comecer SPA. Through this agreement, Bayer and Comecer are providing customers with an integrated nuclear medicine solution – combining the clinical administration capabilities of Intego with the Comecer's protection technologies for PET/CT centers around the world.
Researchers at The Johns Hopkins University and Yale University have discovered that a specialized receptor, normally found in the nose, is also in blood vessels throughout the body, sensing small molecules created by microbes that line mammalian intestines, and responding to these molecules by increasing blood pressure. The finding suggests that gut bacteria are an integral part of the body’s complex system for maintaining a stable blood pressure.
St. Jude Medical Inc. announced plans for a new landmark study that will evaluate whether renal denervation and medication can provide health benefits to patients beyond lowering high blood pressure. The EnligHTNment trial is the first large-scale study that will examine the long-term effects of renal denervation in patients who have uncontrolled hypertension to see if renal denervation also reduces the risk of major cardiovascular events such as heart attack, stroke and death.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
The American College of Radiology supports the Diagnostic Imaging Services Access Protection Act (H.R. 846), recently introduced by Reps. Pete Olson (R-TX), Peter Roskam (R-IL), John Barrow (D-GA), Betty McCollum (D-MN) and 38 House cosponsors. H.R. 846 would correct a 25 percent multiple procedure payment reduction to Medicare reimbursement for interpretation of advanced diagnostic imaging scans performed on the same patient, in the same session.
To address the rising costs of healthcare, we must improve the way that health care is delivered, including coordinating care better and improving the safety of care, stated the Centers for Medicare and Medicaid Services (CMS) in its assessment of healthcare reform, released Feb. 28.
Blood pressure (BP) monitoring technology specialist SunTech Medical will unveil its new cardiac stress BP device at the American College of Cardiology 2013 Scientific Session, March 9-11 in San Francisco.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
Preventice Inc. will showcase its breakthrough mobile health solutions for remote patient monitoring, patient education and patient engagement technologies at the American College of Cardiology (ACC) annual meeting, March 9-11, 2013 in San Francisco.
OrbusNeich announced that OrbusNeich Medical GmbH has commenced patent infringement actions in Germany and The Netherlands against Boston Scientific Corp. and its distribution affiliates in those countries. The complaint alleges Boston Scientific infringed two European patents covering certain novel stent designs.
Specialists at Stony Brook Medicine’s Cerebrovascular and Stroke Center (CVC) are treating patients with a new generation of blood clot removal devices that show promise in successfully revascularizing stroke patients, including those with large vessel blockages. The Solitaire Flow Restoration Device and the Trevo device, approved by Food and Drug Administration (FDA) in 2012 to treat stroke caused by the sudden obstruction of a brain blood vessel (acute ischemic stroke) showed improved results over a previous standard and first generation clot-removal device in clinical trials.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
Medtronic Inc. announced European CE (Conformité Européenne) mark approval for its Engager Transcatheter Aortic Valve Implantation (TAVI) System with transapical delivery catheter. The system is indicated to treat patients with severe aortic stenosis who are at high or extreme risk for surgical aortic valve replacement (SAVR).
The Healthcare Supply Chain Association (HSCA) today launched Medical Device Tax Watch, a website dedicated to raising awareness of efforts of some medical device manufacturers to pass the costs of the medical device excise tax (MDET) to American hospitals, healthcare providers and patients. The new site will be a resource for hospitals and a tool for monitoring the device marketplace, and can be found at www.devicetaxwatch.com.
Corindus Vascular Robotics will showcase its U.S. Food and Drug Administration (FDA)-cleared CorPath 200 Vascular Robotic-Assisted System at the American College of Cardiology 2013 meeting, March 9-11.